Clinical Trial Update: Evaluation of Umeclidinium Bromide in Combination With Fluticasone Furoate in COPD Subjects With an Asthmatic Component [Phase 2]

View source ↗

Summary

Phase 2 trial results evaluate umeclidinium bromide in combination with fluticasone furoate for COPD patients with an asthmatic component; results have been pos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Fluticasone Furoate (fluticasone furoate)
• Umeclidinium bromide (umeclidinium bromide)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Pulmonary Disease, Chronic Obstructive | Phase 2 | Status: COMPLETED | Results posted: 2016-06-28